Tofacitinib
Showing 26 - 50 of 258
Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs
Completed
- Arthritis, Rheumatoid
-
Tokyo, JapanPfizer
Nov 28, 2022
Adherence Of Tofacitinib of Ulcerative Colitis In Clinical
Recruiting
- Ulcerative Colitis
- tofacitinib
-
Alingsås, Sweden
- +12 more
Nov 17, 2022
Systemic Lupus Erythematosus, Cutaneous Lupus Trial in Ann Arbor (Tofacitinib)
Recruiting
- Systemic Lupus Erythematosus
- Cutaneous Lupus
- Tofacitinib
-
Ann Arbor, MichiganUniversity of Michigan Health System: Department of Internal Med
May 2, 2022
Sarcoidosis, Pulmonary, Sarcoidosis Lung, Sarcoidosis Trial in Portland (drug, diagnostic test, genetic)
Completed
- Sarcoidosis, Pulmonary
- +2 more
- Tofacitinib 5mg Oral Tablet [Xeljanz] 16 week trial
- +5 more
-
Portland, OregonOregon Health & Science University
Dec 3, 2021
Immune-Mediated Colitis Trial in Montreal (Tofacitinib 10 mg)
Recruiting
- Immune-Mediated Colitis
- Tofacitinib 10 mg
-
Montreal, Quebec, CanadaSir Mortimer B Davis Jewish General Hospital - CIUSSS Centre-Oue
May 11, 2022
Alopecia Areata Trial in Bangkok (Tofacitinib)
Completed
- Alopecia Areata
- Tofacitinib
-
Bangkok, ThailandInstitute of Dermatology
Mar 28, 2022
Rheumatoid Arthritis, Interstitial Lung Disease Trial in Mexico City (Tofacitinib)
Recruiting
- Rheumatoid Arthritis
- Interstitial Lung Disease
- Tofacitinib
-
Mexico City, Tlalpan, MexicoInstituto Nacional de Enfermedades Respiratorias, Ismael Cosío V
Apr 4, 2022
Vitiligo, Effect of Drug Trial (JAK-2 inhibitor, Topical corticosteroid)
Not yet recruiting
- Vitiligo
- Effect of Drug
- JAK-2 inhibitor
- Topical corticosteroid
- (no location specified)
Mar 19, 2022
COVID-19 Pneumonia Trial in New Haven (Tofacitinib 10 mg, Placebo)
Terminated
- COVID-19 Pneumonia
- Tofacitinib 10 mg
- Placebo
-
New Haven, ConnecticutYale New Haven Health System
Mar 16, 2022
Ulcerative Colitis, Thromboembolism Trial in Madrid (Tofacitinib, Infliximab Adalimumab y Golimumab)
Recruiting
- Ulcerative Colitis
- Thromboembolism
- Tofacitinib
- Infliximab Adalimumab y Golimumab
-
Madrid, SpainHospital Universitario de La Princesa
Aug 2, 2022
Primary Sjögren's Syndrome Trial in Beijing (Tofacitinib)
Recruiting
- Primary Sjögren's Syndrome
- Tofacitinib
-
Beijing, Beijing, ChinaDepartment of Rheumatology and Immunology, Peking University Peo
Feb 28, 2022
TofAcitinib in Routine Care Rheumatoid Arthritis- Cardiovascular
Completed
- Rheumatoid Arthritis
- Tofacitinib
- TNF Inhibitor
-
Boston, MassachusettsBrigham And Women's Hospital
Mar 1, 2022
Patterns And Effect Of Tofacitinib Indicators For Rheumatoid
Completed
- Arthritis, Rheumatoid
-
New York, New YorkPfizer
Jun 8, 2022
That Distinguish Between Tofacitinib Responders and
Completed
- Ulcerative Colitis
- GWAS analysis by Illumina BeadChip
-
New York, New YorkNew York University School of Medicine
Aug 9, 2022
Healthy Subjects Trial in Québec (Tofacitinib Citrate)
Completed
- Healthy Subjects
- Tofacitinib Citrate
-
Québec, CanadaSyneos Health Facility
Nov 25, 2021
Tofacitinib on Body Composition, Bone Mineral Density and Bone
Suspended
- Rheumatoid Arthritis
- Tofacitinib
-
Lille, FranceLille University Hospital
Feb 7, 2022
Tofacitinib PsA Initiators in the CorEvitas SpA Registry
Active, not recruiting
- Psoriatic Arthritis
-
New York, New YorkPfizer
Feb 8, 2022
Discoid Lupus Erythematosus, Systemic Lupus Erythematosus Trial in Boston (Tofacitinib citrate)
Terminated
- Discoid Lupus Erythematosus
- Systemic Lupus Erythematosus
- Tofacitinib citrate
-
Boston, MassachusettsTufts Medical Center
Jan 6, 2022
Ulcerative Colitis Trial in Chapel Hill
Enrolling by invitation
- Ulcerative Colitis
-
Chapel Hill, North CarolinaDivision of Gastroenterology and Hepatology
Feb 21, 2022
Generate Real World Data On Tofacitinib Induction Therapy and
Recruiting
- Ulcerative Colitis
- Stool sample collection
-
Bern, Bern (de), Switzerland
- +8 more
Jan 25, 2023
Tofatib Treatment for IgG4-related Disease
Recruiting
- IgG4-related Disease
- tofacitinib
-
Shanghai, Shanghai, ChinaShanghai Changhai Hospital
Nov 15, 2022
Takayasu Arteritis Trial in Beijing (Adalimumab Injection, Tofacitinib 5 MG)
Recruiting
- Takayasu Arteritis
- Adalimumab Injection
- Tofacitinib 5 MG
-
Beijing, China
- +3 more
Feb 26, 2022
Ulcerative Colitis Trial in Miami (Tofacitinib, Fast Mimicking Diet, Ustekinumab induction)
Recruiting
- Ulcerative Colitis
- Tofacitinib
- +3 more
-
Miami, Florida
- +1 more
Apr 22, 2022